Active, not recruitingPHASE1, PHASE2NCT01966731

Realizing Effectiveness Across Continents With Hydroxyurea (REACH)

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Russell Ware, MD, PhD
Children's Hospital Medical Center, Cincinnati
Intervention
Hydroxyurea(drug)
Enrollment
635 target
Eligibility
1-10 years · All sexes
Timeline
2014 – 2033

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01966731 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials